A nonprofit representing thousands of physicians is suing to restore access to public health data.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
A study found the Oura ring can pinpoint menstrual cycles with 96.4% accuracy.
Cosmo UK explores the phenomenon dubbed ‘post‐birth control syndrome’ despite its unofficial status.
Profiles reveal that women in states with strict abortion bans are avoiding pregnancy for fear of inadequate health care.
Exclusive subscriber content: a comprehensive report on upcoming shifts in women’s health and a 2024 stories database.
New York introduces a shield law to protect doctors who prescribe abortion medications.
A New York physician faces indictment in Louisiana for prescribing abortion pills.
The Trump administration’s removal of CDC pages is disrupting detailed contraceptive guidelines.
KFF Health News reports a woman was billed over $14,000 for an IUD she thought was covered by insurance.
A study finds that higher white blood cell counts in postmenopausal women may signal severe COVID-19.
The debate over rebranding early-stage cancers like DCIS aims to reduce patient anxiety.
A review of over 90,000 drug trials shows that pregnant women are almost entirely excluded.
Michigan law now allows pharmacists to prescribe birth control amid a shortage of OB/GYNs.
Amid administrative chaos, the NIH acting director assured that key research projects would proceed.
Vox examines strategies that might let Trump maintain a moderate image on abortion while enforcing restrictions.
An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.
An analysis of emerging investment trends shaping the future of women’s health research.
Women voice frustrations over intrusive social media ads during perimenopause.
An obituary celebrating Carol Downer’s lifelong advocacy for abortion rights.